These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 19299458)
1. Aberrant histone modifications at the thyrotropin-releasing hormone gene in resistance to thyroid hormone: analysis of F455S mutant thyroid hormone receptor. Umezawa R; Yamada M; Horiguchi K; Ishii S; Hashimoto K; Okada S; Satoh T; Mori M Endocrinology; 2009 Jul; 150(7):3425-32. PubMed ID: 19299458 [TBL] [Abstract][Full Text] [Related]
2. Aberrant dynamics of histone deacetylation at the thyrotropin-releasing hormone gene in resistance to thyroid hormone. Ishii S; Yamada M; Satoh T; Monden T; Hashimoto K; Shibusawa N; Onigata K; Morikawa A; Mori M Mol Endocrinol; 2004 Jul; 18(7):1708-20. PubMed ID: 15131262 [TBL] [Abstract][Full Text] [Related]
3. Distinct and histone-specific modifications mediate positive versus negative transcriptional regulation of TSHalpha promoter. Wang D; Xia X; Weiss RE; Refetoff S; Yen PM PLoS One; 2010 Mar; 5(3):e9853. PubMed ID: 20352046 [TBL] [Abstract][Full Text] [Related]
4. Specific histone lysine 4 methylation patterns define TR-binding capacity and differentiate direct T3 responses. Bilesimo P; Jolivet P; Alfama G; Buisine N; Le Mevel S; Havis E; Demeneix BA; Sachs LM Mol Endocrinol; 2011 Feb; 25(2):225-37. PubMed ID: 21239616 [TBL] [Abstract][Full Text] [Related]
5. RNA polymerase II phosphorylation at serine 2 and histone H3 tri-methylation at lysine 36 are key steps for thyroid hormone receptor β gene activation by thyroid hormone in Rana catesbeiana tadpole liver. Mochizuki K; Ishihara A; Goda T; Yamauchi K Biochem Biophys Res Commun; 2012 Jan; 417(3):1069-73. PubMed ID: 22226961 [TBL] [Abstract][Full Text] [Related]
6. Involvement of histone methylation and phosphorylation in regulation of transcription by thyroid hormone receptor. Li J; Lin Q; Yoon HG; Huang ZQ; Strahl BD; Allis CD; Wong J Mol Cell Biol; 2002 Aug; 22(16):5688-97. PubMed ID: 12138181 [TBL] [Abstract][Full Text] [Related]
7. Ioxynil and tetrabromobisphenol A suppress thyroid-hormone-induced activation of transcriptional elongation mediated by histone modifications and RNA polymerase II phosphorylation. Otsuka S; Ishihara A; Yamauchi K Toxicol Sci; 2014 Apr; 138(2):290-9. PubMed ID: 24449421 [TBL] [Abstract][Full Text] [Related]
8. A novel thyroid hormone receptor-beta mutation that fails to bind nuclear receptor corepressor in a patient as an apparent cause of severe, predominantly pituitary resistance to thyroid hormone. Wu SY; Cohen RN; Simsek E; Senses DA; Yar NE; Grasberger H; Noel J; Refetoff S; Weiss RE J Clin Endocrinol Metab; 2006 May; 91(5):1887-95. PubMed ID: 16464943 [TBL] [Abstract][Full Text] [Related]
9. Resistance to thyroid hormone in a patient without thyroid hormone receptor mutations. Parikh S; Ando S; Schneider A; Skarulis MC; Sarlis NJ; Yen PM Thyroid; 2002 Jan; 12(1):81-6. PubMed ID: 11838736 [TBL] [Abstract][Full Text] [Related]
10. A novel TR beta mutation (R383H) in resistance to thyroid hormone syndrome predominantly impairs corepressor release and negative transcriptional regulation. Clifton-Bligh RJ; de Zegher F; Wagner RL; Collingwood TN; Francois I; Van Helvoirt M; Fletterick RJ; Chatterjee VK Mol Endocrinol; 1998 May; 12(5):609-21. PubMed ID: 9605924 [TBL] [Abstract][Full Text] [Related]
11. Targeted chromatin binding and histone acetylation in vivo by thyroid hormone receptor during amphibian development. Sachs LM; Shi YB Proc Natl Acad Sci U S A; 2000 Nov; 97(24):13138-43. PubMed ID: 11078533 [TBL] [Abstract][Full Text] [Related]
12. Five new families with resistance to thyroid hormone not caused by mutations in the thyroid hormone receptor beta gene. Pohlenz J; Weiss RE; Macchia PE; Pannain S; Lau IT; Ho H; Refetoff S J Clin Endocrinol Metab; 1999 Nov; 84(11):3919-28. PubMed ID: 10566629 [TBL] [Abstract][Full Text] [Related]
13. Defective release of corepressor by hinge mutants of the thyroid hormone receptor found in patients with resistance to thyroid hormone. Safer JD; Cohen RN; Hollenberg AN; Wondisford FE J Biol Chem; 1998 Nov; 273(46):30175-82. PubMed ID: 9804773 [TBL] [Abstract][Full Text] [Related]
14. Syndromes of thyroid hormone resistance. Beck-Peccoz P; Mannavola D; Persani L Ann Endocrinol (Paris); 2005 Jun; 66(3):264-9. PubMed ID: 15988389 [TBL] [Abstract][Full Text] [Related]
15. Coordinated changes in DNA methylation and histone modifications regulate silencing/derepression of luteinizing hormone receptor gene transcription. Zhang Y; Fatima N; Dufau ML Mol Cell Biol; 2005 Sep; 25(18):7929-39. PubMed ID: 16135786 [TBL] [Abstract][Full Text] [Related]
16. Multiple mechanisms regulate H3 acetylation of enhancers in response to thyroid hormone. Præstholm SM; Siersbæk MS; Nielsen R; Zhu X; Hollenberg AN; Cheng SY; Grøntved L PLoS Genet; 2020 May; 16(5):e1008770. PubMed ID: 32453730 [TBL] [Abstract][Full Text] [Related]
17. The thyroid hormone receptor-beta gene mutation R383H is associated with isolated central resistance to thyroid hormone. Safer JD; O'Connor MG; Colan SD; Srinivasan S; Tollin SR; Wondisford FE J Clin Endocrinol Metab; 1999 Sep; 84(9):3099-109. PubMed ID: 10487671 [TBL] [Abstract][Full Text] [Related]
18. Negative regulation of TSHalpha target gene by thyroid hormone involves histone acetylation and corepressor complex dissociation. Wang D; Xia X; Liu Y; Oetting A; Walker RL; Zhu Y; Meltzer P; Cole PA; Shi YB; Yen PM Mol Endocrinol; 2009 May; 23(5):600-9. PubMed ID: 19196836 [TBL] [Abstract][Full Text] [Related]
19. A thyroid hormone receptor mutation that dissociates thyroid hormone regulation of gene expression in vivo. Machado DS; Sabet A; Santiago LA; Sidhaye AR; Chiamolera MI; Ortiga-Carvalho TM; Wondisford FE Proc Natl Acad Sci U S A; 2009 Jun; 106(23):9441-6. PubMed ID: 19439650 [TBL] [Abstract][Full Text] [Related]
20. Regulation of the human TRH (hTRH) gene by human thyroid hormone receptor beta 1 (hTR beta 1) mutants. Li QL; Feng P; Satoh T; Shi ZX; Wang R; Weintraub BD; Wilber JF Endocr Res; 1997 Nov; 23(4):297-309. PubMed ID: 9430820 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]